TERAPIA

FARINGOSEPT RAPID MINT 12 LOZENGES

You're reading an Auto-translation.

Composition

The active substances are:

Lidocaine hydrochloride 2.00 mg

Amylmetacresol 0.60 mg

2,4-Dichlorobenzyl alcohol 1.20 mg

Therapeutic indications

Faringosept Rapid contains amylmetacresol and 2,4-dichlorobenzyl alcohol – both antiseptics – and lidocaine hydrochloride – a local anesthetic for the throat.

Indicated for the local relief of sore throat symptoms in adults and adolescents over 12 years of age.

If after 2 days you do not feel better or feel worse, you should consult a doctor.

Contraindications/Warnings

You should inform your doctor if:

• You have bronchial asthma.
• Your symptoms do not improve after two days or you have fever, headache, nausea, vomiting, or a skin rash.

Dosage and administration

Always use exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.

The recommended doses are as follows:

- Adults and adolescents over 12 years of age: slowly dissolve one lozenge in the mouth, once every 2-3 hours, up to a maximum of 8 lozenges in a 24-hour period (maximum 4 lozenges for adolescents).

Do not allow the medicine to dissolve in the cheek pouch (between the cheek and teeth).

Special warnings

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Driving and using machinery

Observe your response to this medicine. Taken at the recommended dose, this medicine should not affect your reactions or cause drowsiness. However, if you notice any of these effects, avoid driving vehicles or operating heavy machinery.

Packaging

Boxes with PVC-PVDC/aluminum blisters containing 12 lozenges.

Faringosept Rapid Mint 2 mg/0.6 mg/1.2 mg lozenges are green, biconvex, cylindrical lozenges, 19 mm in diameter, with a mint flavor.

Page updated on: 09.06.2021